1. EPMA-World Congress 2015. Issue 1 (May 2016) Authors: Abraham, Jella-Andrea; Golubnitschaja, Olga; Akhmetov, Ildar; Andrews, Russell; Quintana, Leonidas; Andrews, Russell; Baban, Babak; Liu, Jun; Qin, Xu; Wang, Tailing; Mozaffari, Mahmood; Bati, Viktoriia; Meleshko, Tamara; Levchuk, Olga; Boyko, Nadiya; Bauer, Joanna; Boerner, Ewa; Podbielska, Halin... Journal: EPMA journal Issue: Volume 7:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Soluble FcɛRI: A biomarker for IgE‐mediated diseases. Issue 7 (11th March 2019) Authors: Moñino‐Romero, Sherezade; Lexmond, Willem S.; Singer, Josef; Bannert, Christina; Amoah, Abena S.; Yazdanbakhsh, Maria; Boakye, Daniel A.; Jensen‐Jarolim, Erika; Fiebiger, Edda; Szépfalusi, Zsolt Journal: Allergy Issue: Volume 74:Issue 7(2019) Page Start: 1381 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Proof of concept study with an HER-2 mimotope anticancer vaccine deduced from a novel AAV-mimotope library platform. (2nd July 2016) Authors: Singer, Josef; Manzano-Szalai, Krisztina; Fazekas, Judit; Thell, Kathrin; Bentley-Lukschal, Anna; Stremnitzer, Caroline; Roth-Walter, Franziska; Weghofer, Margit; Ritter, Mirko; Pino Tossi, Kerstin; Hörer, Markus; Michaelis, Uwe; Jensen-Jarolim, Erika Journal: Oncoimmunology Issue: Volume 5:Number 7(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cancer vaccines inducing antibody production: more pros than cons. (September 2011) Authors: Jensen-Jarolim, Erika; Singer, Josef Journal: Expert review of vaccines Issue: Volume 10:Number 9(2011) Page Start: 1281 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Cancer vaccines inducing antibody production: more pros than cons. (September 2011) Authors: Jensen-Jarolim, Erika; Singer, Josef Journal: Expert review of vaccines Issue: Volume 10:Number 9(2011) Page Start: 1281 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Cancer vaccines inducing antibody production: more pros than cons. (September 2011) Authors: Jensen-Jarolim, Erika; Singer, Josef Journal: Expert review of vaccines Issue: Volume 10:Number 9(2011) Page Start: 1281 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Cancer vaccines inducing antibody production: more pros than cons. (September 2011) Authors: Jensen-Jarolim, Erika; Singer, Josef Journal: Expert review of vaccines Issue: Volume 10:Number 9(2011) Page Start: 1281 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Cancer vaccines inducing antibody production: more pros than cons. (September 2011) Authors: Jensen-Jarolim, Erika; Singer, Josef Journal: Expert review of vaccines Issue: Volume 10:Number 9(2011) Page Start: 1281 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Precision medicine in clinical oncology: the journey from IgG antibody to IgE. Issue 3 (June 2020) Authors: Fazekas-Singer, Judit; Singer, Josef; Jensen-Jarolim, Erika Journal: Current opinion in allergy and clinical immunology Issue: Volume 20:Issue 3(2020:Jun.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Efficacy and safety of immune checkpoint inhibitors in patients with advanced non–small cell lung cancer (NSCLC): a systematic literature review. (1st January 2020) Authors: Wagner, Gernot; Stollenwerk, Hannah Karolina; Klerings, Irma; Pecherstorfer, Martin; Gartlehner, Gerald; Singer, Josef Journal: Oncoimmunology Issue: Volume 9:Number 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗